Bon Natural Life debuts broccoli-derived sleep wellness line

BON Natural Life (BON) announced the launch of its sleep health product series. Developed using the proprietary “Glucoraphanin-Myrosinase” delivery system, the Company intends for this product to dramatically enhance the bio-activity of glucoraphanin, a vital bio-active compound in broccoli and will be launched under the Company’s owned brand. Broccoli, a nutrient-rich superfood, contains glucoraphanin, a key bio-active compound that undergoes metabolic conversion into sulforaphane in the human body. Sulforaphane has been linked to multiple health benefits, including anti-cancer properties, sleep regulation, neuro-protective effects, digestive health support, anti-inflammatory, antioxidant, and anti-aging effects. However, the enzymatic conversion of glucoraphanin into its active form, sulforaphane, is inefficient making it difficult for the body to fully utilize the health benefits of broccoli. This creates challenges for nutritional utilization and commercial application. The Company believes its patent-pending “Glucoraphanin-Myrosinase” represents an innovative biotechnological delivery system. By ensuring optimal enzymatic activation in the body, it achieves an advanced conversion efficiency of bio-active sulforaphane. This system is intended to help resolve fundamental bio-availability challenges. With its precision-driven design, easy usage, and consumer-friendly format, the Company believes this advancement holds transformative potentials through re-positioning glucoraphanin-sulforaphane in the health and wellness market, which will allow the Company to capitalize on potential revenue opportunities.